Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-Assisted Psychotherapy in Detoxified Patients with Alcohol Use Disorder
2016-002547-42Phase 2Unknown
- Sponsor
- Imperial College London
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of midomafetamine in alcohol use disorder (AUD), sponsored by Imperial College London. Primary endpoint: Feasibility, tolerability, and acceptability of MDMA-assisted psychotherapy. Status: unknown.
02
Drugs
midomafetamine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2016-002547-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002547-42.